ASPIRIN THERAPY VAZALORE Trademark

Trademark Overview


On Monday, February 8, 2021, a trademark application was filed for ASPIRIN THERAPY VAZALORE with the United States Patent and Trademark Office. The USPTO has given the ASPIRIN THERAPY VAZALORE trademark a serial number of 90517922. The federal status of this trademark filing is REGISTERED as of Tuesday, March 29, 2022. This trademark is owned by PLX PHARMA INC.. The ASPIRIN THERAPY VAZALORE trademark is filed in the Pharmaceutical Products category with the following description:

Aspirin
aspirin therapy vazalore

General Information


Serial Number90517922
Word MarkASPIRIN THERAPY VAZALORE
Filing DateMonday, February 8, 2021
Status700 - REGISTERED
Status DateTuesday, March 29, 2022
Registration Number6688135
Registration DateTuesday, March 29, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 12, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "ASPIRIN THERAPY" next to a heart design overlaid with an electrocardiograph line, all above the stylized wording "VAZALORE".
Goods and ServicesAspirin
Disclaimer with Predetermined Text"ASPIRIN THERAPY"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 12, 2021
Primary Code005
First Use Anywhere DateSaturday, August 14, 2021
First Use In Commerce DateSaturday, August 14, 2021

Trademark Owner History


Party NamePLX ACQUISITION COMPANY, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBUFFALO, NY 14225

Party NamePLX PHARMA INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSparta, NJ 07871

Party NamePLX PHARMA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSparta, NJ 07871

Party NamePLX PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSparta, NJ 07871

Trademark Events


Event DateEvent Description
Wednesday, September 20, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 20, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 29, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 22, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 15, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 26, 2022USE AMENDMENT FILED
Friday, February 11, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 26, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 4, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 7, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 2, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 2, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, September 2, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, September 2, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, September 2, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 1, 2021ASSIGNED TO EXAMINER
Thursday, May 13, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 11, 2021NEW APPLICATION ENTERED

Related Keywords


vazalore therapy aspirin